Few people in the UK with early stage Alzheimer’s disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.
Epigenetic profiles of blood cancer cells could aid in diagnosis and treatment
Research in biomedical laboratories has been changing significantly in recent years, to the point that test tubes have given way to computers on many occasions.
November 27, 2024